Palantir vs. UiPath: Which AI-First Software Stock Deserves Your Bet?

The article compares Palantir (PLTR) and UiPath (PATH) as AI-first software stocks, noting Palantir's robust growth with U.S. commercial revenues soaring 71% year-over-year, exceeding a $1 billion annual run rate, and a 239% increase in commercial contract value driven by its Artificial Intelligence Platform (AIP). Conversely, UiPath reported 6% year-over-year revenue growth to $357 million, maintaining strong 110-115% net retention rates and leveraging strategic tech partnerships. Despite Palantir's higher growth and rising EPS estimates, the analysis concludes UiPath presents a more attractive and sustainable investment opportunity due to its significantly lower forward sales multiple of 4.07X compared to Palantir's 72.9X, emphasizing its stable business model and ecosystem integration.

Analysis

The comparison between Palantir (PLTR) and UiPath (PATH) highlights a classic growth versus value trade-off in the AI software sector. Palantir is demonstrating explosive expansion, primarily driven by its Artificial Intelligence Platform (AIP), which propelled its U.S. commercial revenues up by 71% year-over-year and its commercial contract value by 239%. This performance, which includes doubling its number of million-dollar-plus deals, has pushed its U.S. commercial business past a $1 billion annual run rate. Consensus estimates support this momentum, forecasting 37% sales and 41% EPS growth for 2025 with upwardly trending revisions. In contrast, UiPath exhibits more moderate, stable growth, with revenues increasing 6% year-over-year to $357 million and annual recurring revenue rising 12%. UiPath's strengths lie in its established market leadership in robotic process automation (RPA), high customer stickiness evidenced by a 110-115% net retention rate, and strategic ecosystem integrations with tech giants. However, this stability is coupled with slower growth projections and downward trending EPS estimates. The core divergence is in valuation: Palantir trades at a steep 72.9X forward sales multiple, whereas UiPath is priced at a much lower 4.07X, presenting a stark choice between paying a premium for hyper-growth and investing in sustainable, lower-multiple enterprise integration.

Key Decisions for Investors

• Investors with a high-risk tolerance focused on hyper-growth could consider Palantir, but must be confident its rapid AIP adoption and 71% commercial revenue growth can be sustained to justify its premium 72.9X forward sales multiple.
• Value-conscious investors or those seeking a lower-risk entry into AI software may find UiPath more attractive, given its significantly lower 4.07X forward sales multiple, strong 110-115% net retention, and established enterprise partnerships.
• A key risk to monitor for UiPath is the downward trend in its EPS estimates and modest 6% revenue growth; an acceleration in these metrics would strengthen the investment case.
• For Palantir, continued momentum in securing large contracts and maintaining its aggressive growth trajectory is critical to supporting its valuation, making contract value reports a key indicator to watch.